NO20080788L - Aripiprazolsalter - Google Patents

Aripiprazolsalter

Info

Publication number
NO20080788L
NO20080788L NO20080788A NO20080788A NO20080788L NO 20080788 L NO20080788 L NO 20080788L NO 20080788 A NO20080788 A NO 20080788A NO 20080788 A NO20080788 A NO 20080788A NO 20080788 L NO20080788 L NO 20080788L
Authority
NO
Norway
Prior art keywords
aripiprazole
salts
present
tobasic
general formula
Prior art date
Application number
NO20080788A
Other languages
English (en)
Inventor
Gyula Simig
Laszlo Pongo
Andras Dancso
Gyorgy Morovjan
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Publication of NO20080788L publication Critical patent/NO20080788L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse tilveiebringer nye salter av aripiprazol med den generelle formel (II) dannet med tobasiske organiske syrer, kamfersulfonsyre, fosforsyre, og fremgangsmåter for deres fremstilling. Ytterligere formål for den foreliggende oppfinnelse er farmasøytiske blandinger inneholdende de nevnte nye aripiprazolsalter. Aripiprazolsalter ifølge den foreliggende oppfinnelse kan fremstilles ved omsetning av aripiprazolbase og egnede syreforbindelser i et molart forhold 0,5-3 basert på den molare mengde aripiprazol i et passende organisk løsningsmiddel.
NO20080788A 2005-07-14 2008-02-13 Aripiprazolsalter NO20080788L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0500683A HUP0500683A3 (en) 2005-07-14 2005-07-14 New arylpiprazole salts for producing pharmaceutical composition
PCT/HU2006/000056 WO2007007132A1 (en) 2005-07-14 2006-07-11 Aripiprazole salts

Publications (1)

Publication Number Publication Date
NO20080788L true NO20080788L (no) 2008-02-13

Family

ID=89986146

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080788A NO20080788L (no) 2005-07-14 2008-02-13 Aripiprazolsalter

Country Status (11)

Country Link
US (1) US20090111829A1 (no)
EP (1) EP1907364A1 (no)
JP (1) JP2009501204A (no)
CN (1) CN101238105A (no)
BG (1) BG110058A (no)
EA (1) EA200800304A1 (no)
HU (1) HUP0500683A3 (no)
NO (1) NO20080788L (no)
RU (1) RU2384572C2 (no)
SK (1) SK50152008A3 (no)
WO (1) WO2007007132A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7714129B2 (en) 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
FR2929943B1 (fr) 2008-04-15 2010-09-24 Inst Rech Developpement Ird Sels de quinoleines 2-substituees
EP2233471A1 (en) * 2009-02-06 2010-09-29 Adamed Sp. z o.o. A salt of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-quinolinone with 5-sulfosalicylic acid and its preparation process
CN102106806B (zh) * 2009-12-29 2013-04-17 上海中西制药有限公司 一种固体制剂的制备方法及所得固体制剂
US9241876B2 (en) * 2011-06-27 2016-01-26 Shanghai Zhongxi Pharmaceutical Corporation Aripiprazole medicament formulation and preparation method therefor
CN111909086B (zh) * 2020-05-05 2022-05-20 天津大学 阿立哌唑-乙酰水杨酸盐及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2608788B2 (ja) * 1988-10-31 1997-05-14 大塚製薬 株式会社 精神***病治療剤
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US20060270683A1 (en) * 2003-04-25 2006-11-30 Lohray Braj B Polymorphs of aripiprazole
CA2594690C (en) * 2005-01-27 2013-08-27 Sandoz Ag Salts of aripiprazole

Also Published As

Publication number Publication date
US20090111829A1 (en) 2009-04-30
HU0500683D0 (en) 2005-10-28
SK50152008A3 (sk) 2008-06-06
RU2008105289A (ru) 2009-08-20
EP1907364A1 (en) 2008-04-09
CN101238105A (zh) 2008-08-06
HUP0500683A2 (en) 2007-12-28
JP2009501204A (ja) 2009-01-15
HUP0500683A3 (en) 2009-03-30
BG110058A (bg) 2008-09-30
WO2007007132A1 (en) 2007-01-18
RU2384572C2 (ru) 2010-03-20
EA200800304A1 (ru) 2008-06-30

Similar Documents

Publication Publication Date Title
NO20080788L (no) Aripiprazolsalter
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085068L (no) Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085067L (no) 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
TW200640918A (en) Isoxazoline derivative and novel process for its preparation
TW200732323A (en) Organic compounds
WO2007025709A3 (en) Organic compounds
WO2007085451A3 (en) 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents
MY160542A (en) An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
WO2006077025A3 (en) Morpholines as 5ht2c agonists
NO20076006L (no) Acetylenderivater
TNSN06407A1 (en) 1-aza-bicyclo [3.3.1] nonanes
BRPI0514448A (pt) derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias
SG158864A1 (en) Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1- carboxylic acid derivatives and related compounds
ME00680B (me) Nova jedinjenja diozmetina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
EP3020397A3 (en) Process for the manufacture of ajoene derivatives
WO2008080891A3 (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
WO2007083060A3 (fr) Derives de chalcone a activite antimitotique
WO2006034822A8 (de) Neue substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel
WO2008045673A3 (en) Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents
WO2008091752A3 (en) Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
WO2007068473A3 (en) Organic compounds
EA200801960A1 (ru) Соли дулоксетина

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application